Case builds for mixing COVID-19 vaccine doses

It looks promising, but the evidence is not there yet, expert says

Australia will eventually move to a heterologous COVID-19 vaccination regimen if the evidence firms up, a leading infectious diseases specialist predicts.

Associate Professor Paul Griffin
Associate Professor Paul Griffin.

Associate Professor Paul Griffin has responded to the weekend news that Canadian health authorities have recommended people who have received a first dose of AstraZeneca’s